Large-cap Health Care company Humana has logged a -1.3% change today on a trading volume of 94,459. The average volume for the stock is 1,505,382.
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. Based in Louisville, United States the company has 67,100 full time employees and a market cap of $57,980,727,296. Humana currently offers its equity investors a dividend that yields 0.7% per year.
The company is now trading -20.17% away from its average analyst target price of $581.27 per share. The 22 analysts following the stock have set target prices ranging from $468.0 to $640.0, and on average give Humana a rating of buy.
Over the last 12 months HUM shares have declined by -3.0%, which represents a difference of -17.0% when compared to the S&P 500. The stock's 52 week high is $571.3 per share and its 52 week low is $423.29. With its net margins declining an average -8.1% over the last 6 years, Humana declining profitability gives us reason to believe its stock price will continue to underwhelm.
|Date Reported||Total Revenue ($ k)||Net Profit ($ k)||Net Margins (%)||YoY Growth (%)|